Newsletters
Read the Blog
Drug-Drug Interactions - What you Should Know
Drugs are a critical part of the prevention and treatment of diseases. While drug treatments are necessary for their positive impact on the quality of patients’ lives, the increasing number of drugs available on the market means a greater potential for drug-drug interactions (DDIs).
NEWSLETTERS
-
Newsletter
December 2019
A FIH case study, scientific posters, webinars, and our latest validated assays.
-
-
-
Newsletter
March 2019
Bold new look, how to overcome bioanalytical challenges, and case studies on hybrid medicines, 505(b)(2), and drug interactions
-
Newsletter
December 2018
Get the Scoop – Cases studies on biosimilars and metabolic disorders, get an exclusive first look at our newly expanded ligand binding bioanalytical laboratory, our experts weigh in on the latest evolution in Microsampling, and more!
-
Newsletter
September 2018
Get the Scoop – A case study evaluating the abuse potential of Mirogabalin, news on our upcoming acquisition, the top trends influencing the CRO industry, and more!
-
Newsletter
April 2018
Get the Scoop – A case study on cannabis, our latest assay list, and much more!